|
Avaliação DCF da Corporação Glaukos (GKOS)
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Glaukos Corporation (GKOS) Bundle
Simplifique a avaliação da Glaukos Corporation (GKOS) com esta calculadora DCF personalizável! Apresentando o Real Glaukos Corporation (GKOS) e os insumos de previsão ajustável, você pode testar cenários e descobrir valor justo da Glaukos Corporation (GKOS) em minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 225.0 | 294.0 | 282.9 | 314.7 | 383.5 | 441.0 | 507.2 | 583.3 | 670.8 | 771.4 |
| Revenue Growth, % | 0 | 30.7 | -3.79 | 11.26 | 21.85 | 15 | 15 | 15 | 15 | 15 |
| EBITDA | -83.6 | -1.5 | -48.8 | -82.1 | -95.6 | -93.4 | -107.5 | -123.6 | -142.1 | -163.4 |
| EBITDA, % | -37.16 | -0.50134 | -17.24 | -26.09 | -24.94 | -21.19 | -21.19 | -21.19 | -21.19 | -21.19 |
| Depreciation | 34.6 | 34.4 | 35.9 | 38.0 | 39.9 | 54.9 | 63.2 | 72.7 | 83.6 | 96.1 |
| Depreciation, % | 15.39 | 11.71 | 12.71 | 12.07 | 10.41 | 12.46 | 12.46 | 12.46 | 12.46 | 12.46 |
| EBIT | -118.2 | -35.9 | -84.7 | -120.1 | -135.6 | -148.4 | -170.6 | -196.2 | -225.7 | -259.5 |
| EBIT, % | -52.54 | -12.21 | -29.95 | -38.16 | -35.35 | -33.64 | -33.64 | -33.64 | -33.64 | -33.64 |
| Total Cash | 404.4 | 414.1 | 352.7 | 295.4 | 318.9 | 420.8 | 483.9 | 556.5 | 640.0 | 736.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 36.1 | 33.4 | 36.1 | 39.9 | 60.7 | 60.6 | 69.6 | 80.1 | 92.1 | 105.9 |
| Account Receivables, % | 16.03 | 11.37 | 12.75 | 12.66 | 15.84 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 |
| Inventories | 15.8 | 23.0 | 37.8 | 42.0 | 57.7 | 49.9 | 57.4 | 66.0 | 76.0 | 87.3 |
| Inventories, % | 7.03 | 7.83 | 13.38 | 13.34 | 15.04 | 11.32 | 11.32 | 11.32 | 11.32 | 11.32 |
| Accounts Payable | 4.4 | 7.3 | 14.4 | 13.4 | 13.0 | 15.2 | 17.4 | 20.1 | 23.1 | 26.5 |
| Accounts Payable, % | 1.94 | 2.49 | 5.09 | 4.27 | 3.4 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 |
| Capital Expenditure | -6.9 | -47.8 | -30.3 | -20.2 | -6.3 | -33.6 | -38.7 | -44.5 | -51.1 | -58.8 |
| Capital Expenditure, % | -3.08 | -16.25 | -10.7 | -6.43 | -1.64 | -7.62 | -7.62 | -7.62 | -7.62 | -7.62 |
| Tax Rate, % | -0.52953 | -0.52953 | -0.52953 | -0.52953 | -0.52953 | -0.52953 | -0.52953 | -0.52953 | -0.52953 | -0.52953 |
| EBITAT | -107.5 | -36.1 | -85.4 | -120.9 | -136.3 | -145.7 | -167.5 | -192.7 | -221.6 | -254.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -127.3 | -51.1 | -90.1 | -112.1 | -139.7 | -114.3 | -157.3 | -180.9 | -208.1 | -239.3 |
| WACC, % | 8.97 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 | 8.98 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -680.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -244 | |||||||||
| Terminal Value | -3,496 | |||||||||
| Present Terminal Value | -2,274 | |||||||||
| Enterprise Value | -2,955 | |||||||||
| Net Debt | -66 | |||||||||
| Equity Value | -2,889 | |||||||||
| Diluted Shares Outstanding, MM | 53 | |||||||||
| Equity Value Per Share | -54.75 |
What You Will Get
- Real GKOS Financial Data: Pre-filled with Glaukos Corporation’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Glaukos Corporation’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential parameters such as revenue projections, EBITDA margins, and capital investments.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
- High-Precision Results: Leverages Glaukos Corporation's (GKOS) real financial data for accurate valuation insights.
- Effortless Scenario Testing: Easily explore various assumptions and analyze the resulting impacts.
- Efficiency Booster: Streamline the valuation process by avoiding the complexities of building models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Glaukos Corporation’s pre-filled financial data and forecasts.
- Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you tweak assumptions.
- Step 5: Analyze the outputs and use the results for investment decisions regarding Glaukos Corporation (GKOS).
Why Choose This Calculator for Glaukos Corporation (GKOS)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and healthcare consultants.
- Accurate Data: Glaukos Corporation's historical and projected financials are preloaded for precision.
- Forecast Scenarios: Easily simulate various projections and assumptions for informed decision-making.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a seamless experience throughout the process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for Glaukos Corporation (GKOS) analysis.
- Corporate Finance Departments: Evaluate valuation scenarios to inform strategic decisions within the company.
- Consultants and Financial Advisors: Deliver precise valuation insights to clients interested in Glaukos Corporation (GKOS) stock.
- Students and Instructors: Utilize real-time data to enhance learning and practice in financial modeling.
- Medical Technology Enthusiasts: Gain insights into how companies like Glaukos Corporation (GKOS) are valued in the healthcare market.
What the Glaukos Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Glaukos Corporation (GKOS).
- Real-World Data: Glaukos’ historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Interactive charts and tables providing clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.